Back to News
nMarch 6, 2023

Part 3 - Big Biz Show TV Interview with HeartSciences (HSCS) CEO Andrew Simpson - Radically Increasing the Value of an ECG

"Skip to content\nHome\nProducts\nClinical\nNews\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nPart 3 – Big Biz Show TV Interview with HeartSciences (HSCS) CEO Andrew Simpson – Radically Increasing the Value of an ECG\nMarch 6, 2023\n\nHeartSciences (HSCS) CEO Andrew Simpson talks about the need to address the biggest killer of people in the United States through a low cost, simple to perform test such as the EKG.\n\nHeartSciences is applying advanced science and then machine learning or artificial intelligence (AI) to the EKG to make it a much more valuable tool to screen for a much broader range of heart disease.\nThis way, through an EKG screening you might be able to know well ahead of time about an issue related to cardiac dysfunction and then do something about it.\nSee video post here:  https://twitter.com/i/status/1632801003232690178\nContacts\nMEDIA RELATIONS\n\nGene Gephart\nDirector of Marketing\n+1-682-244-2578 (US)\n\ngene.gephart@heartsciences.com\nINVESTOR CONTACT\n\nMark Komonoski – Partner\nIntegrous Communications\nDirect: 877-255-8483\n\ninvestorrelations@heartsciences.com\nwww.integcom.us\n